Two plasma membrane fractions were obtained from different regions of brains from patients with Alzheimer''s disease (AD) and normal aged individuals. One fraction was from synaptosomes (synaptosomal plasma membrane; SPM) and the other from glial cells and neuronal cell bodies (plasma membrane; PM). Among various regions analyzed, PM and SPM from the nucleus basalis of AD brains displayed 6- to 8-fold higher activities of mono- and diacylglycerol lipases than membranes from age-matched normal individuals. Membranes from the hippocampus region of AD brains also showed consistently higher activities of lipases than those from control brains. Similarly, the lysophospholipase activity in the cytosolic fraction of these regions also showed higher activity (4- to 6-fold) in AD than in corresponding fractions from normal human brains. The cause of increased activities of lipases and lysophospholipases in the nucleus basalis and hippocampus regions is not understood. However, marked elevations of acylhydrolases in the above regions may be due to overexpression, changes in levels of neuropeptides, intracellular calcium ions and/or lipid peroxides. All these are known to stimulate acylhydrolases. Autolytic changes which occur in the brain after death may markedly affect the activities of mono- and diacylglycerol lipases.

Keywords:
Alzheimer's disease, Membrane phospholipids, Monoacylglycerol lipase, Diacylglycerol lipase, Lysophospholipase, Plasma membrane, Synaptosomal plasma membrane, Aging, Lipid peroxidation, Membrane fluidity
This content is only available via PDF.
© 1990 S. Karger AG, Basel
1991
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.